Last reviewed · How we verify
0.2% hyaluronic acid gel
At a glance
| Generic name | 0.2% hyaluronic acid gel |
|---|---|
| Also known as | Gengigel |
| Sponsor | University of Medicine and Pharmacy at Ho Chi Minh City |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Resveratrol-Based Gel Application in a Palatal Wound Following Free Gingival Graft Surgery (NA)
- Influence of Hyaluronic Acid in the Healing of Palatal Donor Sites During Free Gingival Graft Procedures (NA)
- Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel (PHASE1)
- Clinical Evaluation of Hyaluronic Acid and Platelet Rich Fibrin Injection Efficacy in Interdental Papilla Reconstruction (PHASE4)
- Testing the Efficacy of Photobiomodulation Therapy and Hyaluronic Acid Gel on Post-surgical Healing After Gingivectomy (EARLY_PHASE1)
- Papillary Reconstruction Using Three Different Modalities (NA)
- Clinical Evaluation of Photobiomodulated Hyaluronic Acid Therapy for Interdental Papillary Loss: Minimal Invasive Blind Split Mouth Technique (PHASE1, PHASE2)
- Testing Sodium Hypochlorite and Hyaluronic Acid as an Adjunct to Non-Invasive Therapy for Stage III Periodontitis Management (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: